APO Research
Talk to an analyst

APO RESEARCH · REPORT

Soliris

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.

Selected research

Market Structure

Global Soliris Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025179 pages

Choose your research edition.

Industry ResearchSoliris Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Soliris Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Soliris Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Soliris Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Soliris Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.

Prior to COVID-19, the China market for Soliris was anticipated to grow from US$ 43.15 million in 2020 to US$ 105.67 million by 2026; it is expected to grow at a CAGR of 14.86% during 2021–2026, whereas post-COVID-19 scenario, the market for Soliris is projected to grow from US$ 40.9 million in 2020 (a change by ~-6.4% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 100.58 million by 2026; it is expected to grow at a CAGR of 14.75% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Soliris market.The classification of Soliris includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2019 is about 76.36%, and the proportion is in increasing trend from 2013 to 2018.

Soliris is widely used for patients of PNH, aHUS and other. The most proportion of Soliris is used for patients of PNH, and the proportion in 2019 is 66.85%.

Read the full market overview

This report provides an overview of the global Soliris market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Soliris and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Soliris sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Soliris market size, projected growth trends, production technologies, key applications, and end-use industries.

Soliris Segment by Company

Alexion

Soliris Segment by Type

Plasma Exchange

Plasma Infusion

Soliris Segment by Application

PNH

aHUS

Other

Soliris Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soliris market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Soliris and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soliris.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Soliris market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Soliris manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Soliris in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Soliris in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Soliris Industry Trends Table 2. Soliris Industry Drivers Table 3. Soliris Industry Opportunities and Challenges Table 4. Soliris Industry Restraints Table 5. Global Soliris Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Soliris Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Soliris Sales by Manufacturers (Unit) & (2021-2026) Table 8. Global Soliris Sales Market Share by Manufacturers Table 9. Global Soliris Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Soliris Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Soliris Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Soliris Manufacturers, Product Type & Application Table 13. Global Soliris Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Soliris by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plasma Exchange Table 17. Major Manufacturers of Plasma Infusion Table 18. Global Soliris Sales by Type 2021 VS 2025 VS 2032 (Unit) Table 19. Global Soliris Sales by Type (2021-2026) & (Unit) Table 20. Global Soliris Sales by Type (2027-2032) & (Unit) Table 21. Global Soliris Sales Market Share by Type (2021-2026) Table 22. Global Soliris Sales Market Share by Type (2027-2032) Table 23. Global Soliris Revenue by Type 2021 VS 2025 VS 2032 (Unit) Table 24. Global Soliris Revenue by Type (2021-2026) & (Unit) Table 25. Global Soliris Revenue by Type (2027-2032) & (Unit) Table 26. Global Soliris Revenue Market Share by Type (2021-2026) Table 27. Global Soliris Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of PNH Table 29. Major Manufacturers of aHUS Table 30. Major Manufacturers of Other Table 31. Global Soliris Sales by Application 2021 VS 2025 VS 2032 (Unit) Table 32. Global Soliris Sales by Application (2021-2026) & (Unit) Table 33. Global Soliris Sales by Application (2027-2032) & (Unit) Table 34. Global Soliris Sales Market Share by Application (2021-2026) Table 35. Global Soliris Sales Market Share by Application (2027-2032) Table 36. Global Soliris Revenue by Application 2021 VS 2025 VS 2032 (Unit) Table 37. Global Soliris Revenue by Application (2021-2026) & (Unit) Table 38. Global Soliris Revenue by Application (2027-2032) & (Unit) Table 39. Global Soliris Revenue Market Share by Application (2021-2026) Table 40. Global Soliris Revenue Market Share by Application (2027-2032) Table 41. Global Soliris Sales by Region: 2021 VS 2025 VS 2032 (Unit) Table 42. Global Soliris Sales by Region (2021-2026) & (Unit) Table 43. Global Soliris Sales Market Share by Region (2021-2026) Table 44. Global Soliris Sales Forecasted by Region (2027-2032) & (Unit) Table 45. Global Soliris Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Soliris Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Unit) Table 47. North America Soliris Sales by Country (2021-2026) & (Unit) Table 48. North America Soliris Sales by Country (2027-2032) & (Unit) Table 49. Europe Soliris Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Unit) Table 50. Europe Soliris Sales by Country (2021-2026) & (Unit) Table 51. Europe Soliris Sales by Country (2027-2032) & (Unit) Table 52. Asia Pacific Soliris Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Unit) Table 53. Asia Pacific Soliris Sales by Country (2021-2026) & (Unit) Table 54. Asia Pacific Soliris Sales by Country (2027-2032) & (Unit) Table 55. South America, Middle East and Africa Soliris Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Unit) Table 56. South America, Middle East and Africa Soliris Sales by Country (2021-2026) & (Unit) Table 57. South America, Middle East and Africa Soliris Sales by Country (2027-2032) & (Unit) Table 58. Global Soliris Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Soliris Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Soliris Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Soliris Revenue Market Share by Region (2021-2026) Table 62. Global Soliris Revenue Market Share by Region (2027-2032) Table 63. Alexion Company Information Table 64. Alexion Business Overview Table 65. Alexion Soliris Sales (Unit), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Alexion Soliris Product Portfolio Table 67. Alexion Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Soliris Distributors List Table 71. Soliris Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Soliris Product Image Figure 2. Global Soliris Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Soliris Market Size (2021-2032) & (US$ Million) Figure 4. Global Soliris Sales (2021-2032) & (Unit) Figure 5. Global Soliris Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Soliris Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plasma Exchange Image Figure 9. Plasma Infusion Image Figure 10. Global Soliris Sales by Type (2021 VS 2025 VS 2032) & (Unit) Figure 11. Global Soliris Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Soliris Sales Market Share by Type (2021-2032) Figure 13. Global Soliris Revenue by Type (2021 VS 2025 VS 2032) & (Unit) Figure 14. Global Soliris Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Soliris Revenue Market Share by Type (2021-2032) Figure 16. PNH Image Figure 17. aHUS Image Figure 18. Other Image Figure 19. Global Soliris Sales by Application (2021 VS 2025 VS 2032) & (Unit) Figure 20. Global Soliris Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Soliris Sales Market Share by Application (2021-2032) Figure 22. Global Soliris Revenue by Application (2021 VS 2025 VS 2032) & (Unit) Figure 23. Global Soliris Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Soliris Revenue Market Share by Application (2021-2032) Figure 25. North America Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 26. North America Soliris Sales Market Share by Country (2021-2032) Figure 27. U.S. Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 28. Canada Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 29. Mexico Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 30. Europe Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 31. Europe Soliris Sales Market Share by Country (2021-2032) Figure 32. Germany Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 33. France Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 34. U.K. Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 35. Italy Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 36. Netherlands Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 37. Asia Pacific Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 38. Asia Pacific Soliris Sales Market Share by Country (2021-2032) Figure 39. China Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 40. Japan Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 41. South Korea Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 42. Southeast Asia Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 43. India Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 44. Australia Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 45. South America, Middle East and Africa Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 46. South America, Middle East and Africa Soliris Sales Market Share by Country (2021-2032) Figure 47. Brazil Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 48. South Africa Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 49. Saudi Arabia Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 50. Turkey Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 51. Argentina Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 52. UAE Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 53. Egypt Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 54. Chile Soliris Sales and Growth Rate (2021-2032) & (Unit) Figure 55. Global Soliris Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Soliris Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Soliris Revenue (2021-2032) & (US$ Million) Figure 58. North America Soliris Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Soliris Revenue (2021-2032) & (US$ Million) Figure 60. Europe Soliris Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Soliris Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Soliris Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Soliris Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Soliris Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Soliris Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Soliris Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Plasma Exchange
  • Plasma Infusion
Applications
  • PNH
  • aHUS
  • Other
Companies covered
  • Alexion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Soliris Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Soliris Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Soliris Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Soliris Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Soliris Market Dynamics
  1. 2.1 Soliris Industry Trends
  2. 2.2 Soliris Industry Drivers
  3. 2.3 Soliris Industry Opportunities and Challenges
  4. 2.4 Soliris Industry Restraints
3 Soliris Market by Manufacturers
  1. 3.1 Global Soliris Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Soliris Sales by Manufacturers (2021-2026)
  3. 3.3 Global Soliris Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Soliris Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Soliris Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Soliris Manufacturers, Product Type & Application
  7. 3.7 Global Soliris Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Soliris Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Soliris Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Soliris Tier 1, Tier 2, and Tier 3
4 Soliris Market by Type
  1. 4.1 Soliris Type Introduction
  2. 4.1.1 Plasma Exchange
  3. 4.1.2 Plasma Infusion
  4. 4.2 Global Soliris Sales by Type
  5. 4.2.1 Global Soliris Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Soliris Sales by Type (2021-2032)
  7. 4.2.3 Global Soliris Sales Market Share by Type (2021-2032)
  8. 4.3 Global Soliris Revenue by Type
  9. 4.3.1 Global Soliris Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Soliris Revenue by Type (2021-2032)
  11. 4.3.3 Global Soliris Revenue Market Share by Type (2021-2032)
5 Soliris Market by Application
  1. 5.1 Soliris Application Introduction
  2. 5.1.1 PNH
  3. 5.1.2 aHUS
  4. 5.1.3 Other
  5. 5.2 Global Soliris Sales by Application
  6. 5.2.1 Global Soliris Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Soliris Sales by Application (2021-2032)
  8. 5.2.3 Global Soliris Sales Market Share by Application (2021-2032)
  9. 5.3 Global Soliris Revenue by Application
  10. 5.3.1 Global Soliris Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Soliris Revenue by Application (2021-2032)
  12. 5.3.3 Global Soliris Revenue Market Share by Application (2021-2032)
6 Global Soliris Sales by Region
  1. 6.1 Global Soliris Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Soliris Sales by Region (2021-2032)
  3. 6.2.1 Global Soliris Sales by Region (2021-2026)
  4. 6.2.2 Global Soliris Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Soliris Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Soliris Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Soliris Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Soliris Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Soliris Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Soliris Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Soliris Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Soliris Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Soliris Revenue by Region
  1. 7.1 Global Soliris Revenue by Region
  2. 7.1.1 Global Soliris Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Soliris Revenue by Region (2021-2026)
  4. 7.1.3 Global Soliris Revenue by Region (2027-2032)
  5. 7.1.4 Global Soliris Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Soliris Revenue (2021-2032)
  8. 7.2.2 North America Soliris Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Soliris Revenue (2021-2032)
  11. 7.3.2 Europe Soliris Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Soliris Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Soliris Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Soliris Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Soliris Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alexion
  2. 8.1.1 Alexion Company Information
  3. 8.1.2 Alexion Business Overview
  4. 8.1.3 Alexion Soliris Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alexion Soliris Product Portfolio
  6. 8.1.5 Alexion Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Soliris Value Chain Analysis
  2. 9.1.1 Soliris Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Soliris Production Mode & Process
  6. 9.2 Soliris Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Soliris Distributors
  9. 9.2.3 Soliris Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst